Capital Group Global Equity Fund (LUX) C (GBP)Register to Unlock Ratings |
Performance History | 31/05/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 12.3 | 16.5 | -5.1 | 12.6 | 7.0 | |
+/-Cat | 1.8 | -1.5 | 4.2 | -0.2 | -0.4 | |
+/-B’mrk | 0.1 | -3.1 | 2.6 | -2.7 | -2.0 | |
Category: Global Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar Global TME NR USD |
Key Stats | ||
NAV 25/06/2024 | GBP 49.09 | |
Day Change | 0.02% | |
Morningstar Category™ | Global Large-Cap Blend Equity | |
IA (formerly IMA) Sector | Global | |
ISIN | LU0115000134 | |
Fund Size (Mil) 25/06/2024 | USD 768.39 | |
Share Class Size (Mil) 25/06/2024 | EUR 448.64 | |
Max Initial Charge | - | |
Ongoing Charge 31/05/2024 | 0.13% |
Investment Objective: Capital Group Global Equity Fund (LUX) C (GBP) |
Long-term capital growth through investment primarily in listed Equity, researched and selected on a world-wide basis. Unlisted securities may also be purchased, subject to the relevant provisions of the "General Investment Guidelines and Restrictions". |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Philip Winston 22/01/2020 | ||
William Robbins 22/01/2020 | ||
Click here to see others | ||
Inception Date 03/10/2000 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR USD | Morningstar Global TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Capital Group Global Equity Fund (LUX) C (GBP) | 31/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.13 |
Broadcom Inc | Technology | 2.58 |
Microsoft Corp | Technology | 2.37 |
AstraZeneca PLC | Healthcare | 1.99 |
Safran SA | Industrials | 1.98 |
Increase Decrease New since last portfolio | ||
Capital Group Global Equity Fund (LUX) C (GBP) |